Searching for your content...
In-Language News
Contact Us
888-776-0942 from 8 AM - 10 PM ET
Roche (SIX : RO, ROG ; OTCQX : RHHBY), a annoncé aujourd'hui la commercialisation du CMV (cytomégalovirus) cobas® utilisable sur le système...
Roche (SIX: RO, ROG; OTCQX: RHHBY) ha anunciado hoy la disponibilidad comercial de cobas® CMV (citomegalovirus) para su uso en el Sistema...
Roche (SIX: RO, ROG; OTCQX: RHHBY) hat heute die kommerzielle Verfügbarkeit von cobas® CMV (Cytomegalovirus) für sein automatisiertes cobas® 4800...
Roche Molecular Diagnostics (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food & Drug Administration (FDA) has approved the COBAS®...
Roche Molecular Diagnostics (SIX: RO, ROG: OTCQX: RHHBY) announced today that the Food and Drug Administration (FDA) approved its new dual-PCR target ...
Join PR Newswire for Journalists to access all of the free services designated to make your job easier.
In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.